WallStreetZenWallStreetZen

NASDAQ: IDXX
Idexx Laboratories Inc Stock

$539.57+8.97 (+1.69%)
Updated Mar 27, 2024
IDXX Price
$539.57
Fair Value Price
$541.14
Market Cap
$44.83B
52 Week Low
$372.50
52 Week High
$583.39
P/E
53.06x
P/B
30.2x
P/S
12.59x
PEG
5.43x
Dividend Yield
N/A
Revenue
$3.66B
Earnings
$845.04M
Gross Margin
59.8%
Operating Margin
30.12%
Profit Margin
23.1%
Debt to Equity
1.2
Operating Cash Flow
$907M
Beta
1.04
Next Earnings
Apr 30, 2024
Ex-Dividend
N/A
Next Dividend
N/A

IDXX Overview

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IDXX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IDXX ($539.57) is undervalued by 0.29% relative to our estimate of its Fair Value price of $541.14 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
IDXX ($539.57) is not significantly undervalued (0.29%) relative to our estimate of its Fair Value price of $541.14 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
IDXX ($539.57) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IDXX due diligence checks available for Premium users.

Be the first to know about important IDXX news, forecast changes, insider trades & much more!

IDXX News

Valuation

IDXX fair value

Fair Value of IDXX stock based on Discounted Cash Flow (DCF)
Price
$539.57
Fair Value
$541.14
Undervalued by
0.29%
IDXX ($539.57) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IDXX ($539.57) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IDXX ($539.57) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IDXX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
53.06x
Industry
37.3x
Market
44.45x
IDXX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IDXX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

IDXX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
30.2x
Industry
4.36x
IDXX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IDXX price to earnings growth (PEG)

For valuing profitable companies with growth potential
IDXX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

IDXX's financial health

Profit margin

Revenue
$901.6M
Net Income
$194.5M
Profit Margin
21.6%
IDXX's Earnings (EBIT) of $1.10B... subscribe to Premium to read more.
Interest Coverage Financials
IDXX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.3B
Liabilities
$1.8B
Debt to equity
1.2
IDXX's short-term assets ($1.50B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IDXX's short-term assets ($1.50B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IDXX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IDXX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$249.9M
Investing
-$30.4M
Financing
-$101.8M
IDXX's operating cash flow ($906.51M)... subscribe to Premium to read more.
Debt Coverage Financials

IDXX vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
IDXX$44.83B+1.69%53.06x30.20x
IQV$45.84B+1.95%34.18x7.50x
A$43.19B+2.05%34.92x6.98x
MTD$28.69B+1.58%37.00x-191.36x
ICLR$27.18B-0.12%44.17x2.94x

Idexx Laboratories Stock FAQ

What is Idexx Laboratories's quote symbol?

(NASDAQ: IDXX) Idexx Laboratories trades on the NASDAQ under the ticker symbol IDXX. Idexx Laboratories stock quotes can also be displayed as NASDAQ: IDXX.

If you're new to stock investing, here's how to buy Idexx Laboratories stock.

What is the 52 week high and low for Idexx Laboratories (NASDAQ: IDXX)?

(NASDAQ: IDXX) Idexx Laboratories's 52-week high was $583.39, and its 52-week low was $372.50. It is currently -7.51% from its 52-week high and 44.85% from its 52-week low.

How much is Idexx Laboratories stock worth today?

(NASDAQ: IDXX) Idexx Laboratories currently has 83,089,381 outstanding shares. With Idexx Laboratories stock trading at $539.57 per share, the total value of Idexx Laboratories stock (market capitalization) is $44.83B.

Idexx Laboratories stock was originally listed at a price of $3.99 in Dec 31, 1997. If you had invested in Idexx Laboratories stock at $3.99, your return over the last 26 years would have been 13,440.03%, for an annualized return of 20.78% (not including any dividends or dividend reinvestments).

How much is Idexx Laboratories's stock price per share?

(NASDAQ: IDXX) Idexx Laboratories stock price per share is $539.57 today (as of Mar 27, 2024).

What is Idexx Laboratories's Market Cap?

(NASDAQ: IDXX) Idexx Laboratories's market cap is $44.83B, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Idexx Laboratories's market cap is calculated by multiplying IDXX's current stock price of $539.57 by IDXX's total outstanding shares of 83,089,381.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.